Sanofi (OTCMKTS:SNYNF – Get Free Report) is expected to post its results before the market opens on Friday, October 30th. Analysts expect Sanofi to post earnings of $2.79 per share and revenue of $14.80 billion for the quarter.
Sanofi Trading Down 1.6%
SNYNF opened at $83.43 on Wednesday. The firm has a fifty day moving average price of $84.16 and a 200 day moving average price of $88.43. Sanofi has a 1 year low of $76.76 and a 1 year high of $106.34.
About Sanofi
Sanofi is a global pharmaceutical and healthcare company headquartered in Paris, France. The company researches, develops, manufactures and markets prescription medicines and vaccines for patients in markets around the world.
Its principal business areas include immunology, rare diseases, neurology, oncology, rare blood disorders and vaccines. Sanofi’s products include Dupixent, a biologic used to treat several inflammatory conditions; established medicines for specialty-care and general-care indications; and vaccines marketed through its Vaccines division, including products for influenza, polio, meningitis and travel-related diseases.
Sanofi was created in 2004 through the merger of Sanofi-Synthélabo and Aventis, bringing together businesses with roots in several European pharmaceutical companies.
Read More
- Five stocks we like better than Sanofi
- Coca-Cola Stock Is Everything AI Isn’t—And That’s Its Biggest Strength
- Apple’s Foldable iPhone Sold Out in Minutes, But Wall Street Has Questions
- Netflix Is Making Big Changes, But Can It Fix What’s Really Hurting Growth?
- Charging Ahead: Solid Power’s Pilot Line Leaves the Lab
Receive News & Ratings for Sanofi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sanofi and related companies with MarketBeat.com's FREE daily email newsletter.
